Search results for "Relative"

showing 10 items of 1094 documents

Antigens of the major histocompatibility complex in patients with chronic discoid lupus erythematosus.

1990

summary The frequencies of the major histocompatability complex class I, class II and class III antigens were determined in 130 patients (88 women and 42 men) with chronic discoid lupus erythematosus, and compared with those of 764 healthy controls. A significant increase in HLA-B7 (38.0% in the patients vs. 25·8% in the control group), HLA-B8 (29·5% vs. 17·4%), HLA-Cw7 (58·9% vs. 26·1%), HLA-DR2 (46·9% vs. 29·7%), HLA-DR3 (32·0% vs. 19·4%), HLA-DQwi (76·6% vs. 60·5%), and a decrease in HLA-A2 (41·9% vs. 55·7%) was found. The calculated relative risk values for the respective antigens markedly increased when two or more antigens were present in one patient, with a maximum relative risk valu…

MaleRiskmedicine.medical_specialtySystemic diseaseDermatologyHLA-C AntigensMajor histocompatibility complexGastroenterologyHLA-B8 AntigenHLA-B7 AntigenHLA-DR3 AntigenLupus Erythematosus DiscoidAntigenHLA AntigensInternal medicineHLA-DQ AntigensHLA-A2 AntigenmedicineHumansIn patientHLA-DR2 AntigenLupus erythematosusbiologybusiness.industrymedicine.diseaseConnective tissue diseaseRelative riskImmunologyChronic Diseasebiology.proteinFemaleDisease SusceptibilitybusinessChronic discoid lupus erythematosusThe British journal of dermatology
researchProduct

Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study

2018

Abstract Background and aims Familial hypercholesterolemia (FH) is an inherited disorder characterized by high levels of blood cholesterol from birth and premature coronary heart disease. Thus, the identification of FH patients is crucial to prevent or delay the onset of cardiovascular events, and the availability of a tool helping with the diagnosis in the setting of general medicine is essential to improve FH patient identification. Methods This study evaluated the performance of the Dutch Lipid Clinic Network (DLCN) score in FH patients enrolled in the LIPIGEN study, an Italian integrated network aimed at improving the identification of patients with genetic dyslipidaemias, including FH.…

MaleSettore MED/09 - Medicina InternaGenetic testingPredictive Value of TestFamilial hypercholesterolemia030204 cardiovascular system & hematologyDecision Support Technique0302 clinical medicineRetrospective StudieRisk FactorsCardiovascular DiseaseGenetic MarkerProspective Studies030212 general & internal medicineAge of OnsetProspective cohort studyeducation.field_of_studymedicine.diagnostic_testMiddle AgedDutch Lipid Clinic Network score; Familial hypercholesterolemia; Genetic testing; Adult; Age of Onset; Biomarkers; Cardiovascular Diseases; Cholesterol LDL; Female; Genetic Markers; Genetic Predisposition to Disease; Genetic Testing; Humans; Hyperlipoproteinemia Type II; Italy; Male; Middle Aged; Phenotype; Predictive Value of Tests; Prospective Studies; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Decision Support Techniques; Mutation3. Good healthCholesterolPhenotypeItalyCardiovascular DiseasesFemaleCardiology and Cardiovascular MedicineHumanAdultGenetic Markersmedicine.medical_specialtyDutch Lipid Clinic Network scorePopulationFamilial hypercholesterolemiaReproducibility of ResultPhysical examinationDutch Lipid Clinic Network score; Familial hypercholesterolemia; Genetic testing; Cardiology and Cardiovascular MedicineRisk AssessmentLDLDecision Support TechniquesHyperlipoproteinemia Type II03 medical and health sciencesPredictive Value of TestsInternal medicinemedicineHumansGenetic Predisposition to DiseaseFirst-degree relativeseducationRetrospective StudiesGenetic testingDutch Lipid Clinic Network score; Familial hypercholesterolemia; Genetic testingbusiness.industryRisk FactorReproducibility of ResultsSettore MED/13 - ENDOCRINOLOGIABiomarkerCholesterol LDLmedicine.diseaseMissing dataDutch Lipid Clinic Network score Familial hypercholesterolemia Genetic testingProspective StudieMutationAge of onsetbusinessBiomarkers
researchProduct

Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: A comparative risk a…

2014

High blood pressure, blood glucose, serum cholesterol, and BMI are risk factors for cardiovascular diseases and some of these factors also increase the risk of chronic kidney disease and diabetes. We estimated mortality from cardiovascular diseases, chronic kidney disease, and diabetes that was attributable to these four cardiometabolic risk factors for all countries and regions from 1980 to 2010.

MaleSettore MED/09 - Medicina Internakidney diseaseEndocrinology Diabetes and Metabolismhumanoscoste de las enfermedadesDiseaseGlobal HealthCohort StudiesEndocrinologyCost of Illnesscardiovascular diseaseHealth TransitionRisk Factorstransición sanitariaestudios prospectivosRenal Insufficiency Chronic -- complications -- epidemiology -- mortalityevaluación de riesgosRenal InsufficiencyProspective StudiesChronicestudios de cohortesMetabolic Syndromeeducation.field_of_studydiabetesMortality rateAge Factors; Cardiovascular Diseases; Cohort Studies; Cost of Illness; Diabetes Complications; Female; Health Surveys; Humans; Male; Metabolic Syndrome X; Prospective Studies; Renal Insufficiency Chronic; Risk Assessment; Risk Factors; Sex Factors; Spatio-Temporal Analysis; Global Health; Health Transition; Internal Medicine; Endocrinology Diabetes and Metabolism; EndocrinologyMetabolic Syndrome XCardiovascular Diseases -- complications -- epidemiology -- mortalityAge FactorsCardiovascular diseaseDiabetes Mellitus chronic kidney diseaseDiabetes Complications -- epidemiology -- mortalitySciences bio-médicales et agricolesDiabetes and MetabolismCardiovascular Diseasesencuestas de saludFemaleanálisis temporoespacialRisk assessmentcomplicaciones de la diabetesinsuficiencia renalmedicine.medical_specialtyCardiovascular disease; kidney disease; diabetes mortalityPopulationenfermedades cardiovascularesMetabolic Syndrome X -- complications -- epidemiology -- mortalityRisk AssessmentArticleDiabetes ComplicationsSex FactorsSpatio-Temporal Analysiscardiovascular disease; chronic kidney disease; diabetes; mortalityInternal medicineEnvironmental healthDiabetes mellitusmedicineAge Factors; Cardiovascular Diseases; Cohort Studies; Cost of Illness; Diabetes Complications; Female; Health Surveys; Humans; Male; Metabolic Syndrome X; Prospective Studies; Renal Insufficiency Chronic; Risk Assessment; Risk Factors; Sex Factors; Spatio-Temporal Analysis; Global Health; Health Transition; Endocrinology Diabetes and Metabolism; Internal Medicine; EndocrinologyInternal Medicinefactores de riesgoHumansRisk factorRenal Insufficiency Chroniceducationbusiness.industrydiabetes mortalitymedicine.diseasemortalityHealth SurveysEndocrinologyRelative riskAge Factors; Cardiovascular Diseases/complications; Cardiovascular Diseases/epidemiology; Cardiovascular Diseases/mortality; Cohort Studies; Cost of Illness; Diabetes Complications/epidemiology; Diabetes Complications/mortality; Female; Global Health; Health Surveys; Health Transition; Humans; Male; Metabolic Syndrome X/complications; Metabolic Syndrome X/epidemiology; Metabolic Syndrome X/mortality; Prospective Studies; Renal Insufficiency Chronic/complications; Renal Insufficiency Chronic/epidemiology; Renal Insufficiency Chronic/mortality; Risk Assessment; Risk Factors; Sex Factors; Spatio-Temporal Analysisbusinesschronic kidney diseaseKidney diseaseThe Lancet Diabetes and Endocrinology
researchProduct

Validation of an atrial fibrillation risk algorithm in whites and African Americans.

2010

Background We sought to validate a recently published risk algorithm for incident atrial fibrillation (AF) in independent cohorts and other racial groups. Methods We evaluated the performance of a Framingham Heart Study (FHS)-derived risk algorithm modified for 5-year incidence of AF in the FHS (n = 4764 participants) and 2 geographically and racially diverse cohorts in the age range 45 to 95 years: AGES (the Age, Gene/Environment Susceptibility-Reykjavik Study) (n = 4238) and CHS (the Cardiovascular Health Study) (n = 5410, of whom 874 [16.2%] were African Americans). The risk algorithm included age, sex, body mass index, systolic blood pressure, electrocardiographic PR interval, hypertens…

MaleSystoleBlack PeopleBlood PressureKaplan-Meier EstimateArticleWhite PeopleBody Mass IndexCohort StudiesElectrocardiographyFramingham Heart StudySex FactorsRisk FactorsAtrial FibrillationInternal MedicineMedicineHumansRisk factorAgedProportional Hazards ModelsAged 80 and overHeart FailureFramingham Risk Scorebusiness.industryIncidenceAge FactorsMiddle AgedConfidence intervalUnited StatesEuropeRelative riskCohortHypertensionFemalebusinessBody mass indexAlgorithmAlgorithmsCohort studyFollow-Up StudiesArchives of internal medicine
researchProduct

Early life stress and frailty in old age: the Helsinki birth cohort study

2018

Background: Evidence suggests that early life stress (ELS) may extend its effect into adulthood and predispose an individual to adverse health outcomes. We investigated whether wartime parental separation, an indicator of severe ELS, would be associated with frailty in old age. Methods: Of the 972 participants belonging to the present sub-study of the Helsinki Birth Cohort Study, 117 (12. 0%) had been evacuated abroad unaccompanied by their parents in childhood during World War II. Frailty was assessed at a mean age of 71 years according to Fried's criteria. Results: Thirteen frail men (4 separated and 9 non-separated) and 20 frail women (2 separated and 18 non-separated) were identified. C…

MaleWorld War IImedicine.medical_treatmentEarly life stresslcsh:GeriatricsPHENOTYPE3124 Neurology and psychiatryCohort Studies0302 clinical medicineMALTREATMENT030212 general & internal medicineChildFinlandDepression (differential diagnoses)Aged 80 and overRehabilitationFrailtyConfoundingriskitekijätDEPRESSIONPREVALENCE5141 SociologyLife course approachFemaleHEALTHBirth cohortResearch ArticleSEX-DIFFERENCES515 Psychologylife-courseFrail Elderlyearly life stressfrailty03 medical and health sciencesINFLAMMATIONLife-courseterveysvaikutuksetmedicineHumansRisk factornatural experimentAgedADVERSE CHILDHOOD EXPERIENCESbusiness.industryDISABILITY3112 NeurosciencesADULTSstressiEarly life stresslapsuuslcsh:RC952-954.63121 General medicine internal medicine and other clinical medicineRelative risksotalapsetRisk factorGeriatrics and GerontologyNatural experimentbusinessStress Psychological030217 neurology & neurosurgeryFollow-Up StudiesDemographyBMC Geriatrics
researchProduct

Joint Estimation of Relative Risk for Dengue and Zika Infections, Colombia, 2015–2016

2019

We jointly estimated relative risk for dengue and Zika virus disease (Zika) in Colombia, establishing the spatial association between them at the department and city levels for October 2015–December 2016. Cases of dengue and Zika were allocated to the 87 municipalities of 1 department and the 293 census sections of 1 city in Colombia. We fitted 8 hierarchical Bayesian Poisson joint models of relative risk for dengue and Zika, including area- and disease-specific random effects accounting for several spatial patterns of disease risk (clustered or uncorrelated heterogeneity) within and between both diseases. Most of the dengue and Zika high-risk municipalities varied in their risk distributio…

MaleZika virus diseaseEpidemiologylcsh:MedicineDengue virusmedicine.disease_causeZika virusZika virusDengue feverDengueconditional auto-regressive prior0302 clinical medicineRisk FactorsPrevalence030212 general & internal medicineGeography MedicalChildBayesian modelsbiologyZika Virus InfectionMiddle AgedRandom effects modelmultivariate risk modelsInfectious DiseasesGeographyChild PreschoolFemaleAdultMicrobiology (medical)medicine.medical_specialtyAdolescent030231 tropical medicineColombiaRisk mapsHistory 21st CenturyRisk Assessmentlcsh:Infectious and parasitic diseasesYoung Adult03 medical and health sciencesAge DistributionEnvironmental healthmedicineHumanslcsh:RC109-216Estimationdengue virusResearchPublic healthlcsh:RInfant NewbornInfantBayes Theorembiology.organism_classificationmedicine.diseaseRelative riskEmerging Infectious Diseases
researchProduct

Sirolimus exposure and the occurrence of cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation

2018

Sirolimus appears to protect against cytomegalovirus (CMV) in organ transplant recipients. The effect of this drug in allogeneic hematopoietic stem cell transplantation recipients remains unexplored. By means of multivariate continuous-time Markov model analyses, we identified 3 independent covariates that significantly impacted the risk of CMV DNAemia: recipient/donor CMV serostatus, tacrolimus exposure, and sirolimus exposure. CMV-seropositive recipients with CMV-seronegative donors had a significantly higher probability of having detectable CMV DNAemia. Increasing the tacrolimus trough concentration from 0 to 16 ng/mL increased the probability of patients having detectable CMV DNAemia by…

Malebasic (laboratory) research/science0301 basic medicinemedicine.medical_treatmentCytomegalovirusHematopoietic stem cell transplantationGastroenterologyOrgan transplantation0302 clinical medicineRisk FactorsImmunology and AllergyPharmacology (medical)Whole bloodIncidenceHematopoietic Stem Cell Transplantationvirus diseasesMiddle AgedPrognosissurgical procedures operativeCytomegalovirus Infectionscytomegalovirus (CMV) [infection and infectious agents-viral]Femaleantiviral [antibiotic]pharmacokinetics/pharmacodynamicsImmunosuppressive Agentsmedicine.drugAdultmedicine.medical_specialtyinfectious diseasesirolimus [immunosuppressant-mechanistic target of rapamycin]clinical research/practicetacrolimus [immunosuppressant-calcineurin inhibitor]03 medical and health sciencesInternal medicinemedicineHumansTransplantation HomologousTrough ConcentrationViremiabone marrow/hematopoietic stem cell transplantationAgedSirolimusTransplantationbusiness.industryTransplant RecipientsTacrolimus030104 developmental biologySpainRelative riskSirolimusDNA ViralpharmacologybusinessSerostatusFollow-Up Studies030215 immunology
researchProduct

Factors contributing to sex differences in functional outcomes and participation after stroke.

2018

ObjectiveTo examine factors contributing to the sex differences in functional outcomes and participation restriction after stroke.MethodsIndividual participant data on long-term functional outcome or participation restriction (i.e., handicap) were obtained from 11 stroke incidence studies (1993–2014). Multivariable log-binomial regression was used to estimate the female:male relative risk (RR) of poor functional outcome (modified Rankin Scale score >2 or Barthel Index score <20) at 1 year (10 studies, n = 4,852) and 5 years (7 studies, n = 2,226). Multivariable linear regression was used to compare the mean difference (MD) in participation restriction by use of the London Handicap Sca…

Malebusiness.industryBarthel indexIndividual participant dataStroke severityStroke RehabilitationRecovery of Function030204 cardiovascular system & hematologymedicine.diseaseConfidence interval03 medical and health sciences0302 clinical medicineSex FactorsModified Rankin ScaleRisk FactorsRelative riskMedicineHumansFemaleNeurology (clinical)businessStroke incidenceStroke030217 neurology & neurosurgeryDemographyNeurology
researchProduct

Mercury exposure and risk of cardiovascular disease: a nested case-control study in the PREDIMED (PREvention with MEDiterranean Diet) study

2017

Background: Substantial evidence suggests that consuming 1-2 servings of fish per week, particularly oily fish (e.g., salmon, herring, sardines) is beneficial for cardiovascular health due to its high n-3 polyunsaturated fatty acid content. However, there is some concern that the mercury content in fish may increase cardiovascular disease risk, but this relationship remains unclear. Methods: The PREDIMED trial included 7477 participants who were at high risk for cardiovascular disease at baseline. In this study, we evaluated associations between mercury exposure, fish consumption and cardiovascular disease. We randomly selected 147 of the 288 cases diagnosed with cardiovascular disease duri…

Malecompuestos de metilmercurioTime Factorsmodelos logísticosMediterranean diethumanos030204 cardiovascular system & hematologyDiet MediterraneanRecommended Dietary AllowancesDieta mediterrània1471-22610302 clinical medicineRisk Factorsestudios prospectivosevaluación de riesgosOdds RatioOily fishWater Pollutants030212 general & internal medicineProspective StudiesToenail biomarkeruñasmediana edadCiències de la salutAged 80 and overeducation.field_of_studyBioquímica y tecnologíaanciano:Ciencias de la Salud::Salud pública [Materias Investigacion]dietaMALALTIES CARDIOVASCULARSMethylmercury CompoundsMiddle Agedcontaminantes del aguaCardiovascular diseaseCiencias de la saludcociente de probabilidades relativasBiochemistry and technologyCardiovascular DiseasesBody BurdenFemaleCardiology and Cardiovascular Medicinecantidad dietética recomendadaResearch ArticlePREDIMEDmedicine.medical_specialtyPopulationestudios de casos y controlesenfermedades cardiovasculareschemistry.chemical_elementFood ContaminationSistema cardiovascular malaltiesBioquímica i biotecnologiaRisk Assessment03 medical and health sciencesalimentos del marfactores de tiempoEnvironmental healthMediterranean dietmedicineHumansfactores de riesgoMercuri -- Toxicologiaanálisis multifactorialeducationCardivascular diseaseAgedbusiness.industryCase-control studyHealth sciencesOdds ratioMercuryProtective FactorsSurgeryMercury (element)DietLogistic ModelsFishchemistrySeafoodNailsSpainRelative riskCase-Control StudiesNested case-control studyMultivariate AnalysisbusinessWater Pollutants Chemicalcarga corporal
researchProduct

Mortality and cardiovascular disease burden of uncontrolled diabetes in a registry-based cohort: the ESCARVAL-risk study

2018

Background: Despite the epidemiological evidence about the relationship between diabetes, mortality and cardiovascular disease, information about the population impact of uncontrolled diabetes is scarce. We aimed to estimate the attributable risk associated with HbA1c levels for all-cause mortality and cardiovascular hospitalization.Methods: Prospective study of subjects with diabetes mellitus using electronic health records from the universal public health system in the Valencian Community, Spain 2008–2012. We included 19,140 men and women aged 30 years or older with diabetes who underwent routine health examinations in primary care.Results: A total of 11,003 (57%) patients had uncontrolle…

Malelcsh:Diseases of the circulatory (Cardiovascular) systemTime Factors030204 cardiovascular system & hematologyPatient Admission0302 clinical medicineRisk FactorsCause of DeathEpidemiologyattributable riskElectronic Health RecordsProspective StudiesRegistries030212 general & internal medicineProspective cohort studyStrokediabetesDiabetesMiddle AgedPrognosisAll-cause mortalitystrokeCor MalaltiesHospitalizationCoronary heart diseaseStrokeCardiovascular DiseasesCohortall-cause mortalityFemaleAttributable riskCardiology and Cardiovascular MedicinehospitalizationResearch ArticleAdultmedicine.medical_specialtyHbA1cRisk Assessment03 medical and health sciencesInternal medicineDiabetes mellitusDiabetes MellitusmedicineHumansHypoglycemic Agentscoronary heart diseaseDisease burdenAgedGlycated HemoglobinPrimary Health Carebusiness.industrymedicine.diseaselcsh:RC666-701SpainRelative riskAttributable riskbusinessBiomarkersBMC Cardiovascular Disorders
researchProduct